- Home
- AGIO vs FLYW Comparison
AGIO vs FLYW Comparison
Compare AGIO & FLYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- FLYW
- Stock Information
- Founded
- AGIO 2007
- FLYW 2009
- Country
- AGIO United States
- FLYW United States
- Employees
- AGIO N/A
- FLYW N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- FLYW Computer Software: Prepackaged Software
- Sector
- AGIO Health Care
- FLYW Technology
- Exchange
- AGIO Nasdaq
- FLYW Nasdaq
- Market Cap
- AGIO 2.0B
- FLYW 2.2B
- IPO Year
- AGIO 2013
- FLYW 2021
- Fundamental
- Price
- AGIO $33.23
- FLYW $19.36
- Analyst Decision
- AGIO Buy
- FLYW Strong Buy
- Analyst Count
- AGIO 7
- FLYW 15
- Target Price
- AGIO $56.33
- FLYW $25.36
- AVG Volume (30 Days)
- AGIO 975.9K
- FLYW 1.3M
- Earning Date
- AGIO 02-13-2025
- FLYW 02-25-2025
- Dividend Yield
- AGIO N/A
- FLYW N/A
- EPS Growth
- AGIO N/A
- FLYW N/A
- EPS
- AGIO 11.80
- FLYW 0.16
- Revenue
- AGIO $32,871,000.00
- FLYW $475,139,000.00
- Revenue This Year
- AGIO $33.41
- FLYW $23.42
- Revenue Next Year
- AGIO $172.14
- FLYW $23.29
- P/E Ratio
- AGIO $2.78
- FLYW $120.04
- Revenue Growth
- AGIO 36.79
- FLYW 26.50
- 52 Week Low
- AGIO $21.18
- FLYW $15.19
- 52 Week High
- AGIO $62.58
- FLYW $31.54
- Technical
- Relative Strength Index (RSI)
- AGIO 36.88
- FLYW 45.19
- Support Level
- AGIO $31.39
- FLYW $17.50
- Resistance Level
- AGIO $35.03
- FLYW $20.69
- Average True Range (ATR)
- AGIO 1.71
- FLYW 0.79
- MACD
- AGIO 0.54
- FLYW 0.05
- Stochastic Oscillator
- AGIO 39.91
- FLYW 55.19
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
About FLYW Flywire Corporation Voting
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements namely a payments platform; a proprietary global payment network and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.